Naboctate
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (6,6,9-trimethyl-3-nonan-2-yl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) 4-(diethylamino)butanoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 74912-19-9 |
| ATC code | ? |
| PubChem | CID 3033579 |
| UNII | N6YFU80HRG |
| Chemical data | |
| Formula | C33H53NO3 |
| Mol. mass | 511.777 g/mol |
|
|
| |
|
Naboctate (SP-325) is a synthetic cannabinoid receptor agonist, which has antiemetic, sedative, anxiolytic and anti-glaucoma properties.[1]
References [edit]
- ^ Concise dictionary of pharmacological agents: properties and synonyms. p188. ISBN 0-7514-0499-3